COMMUNIQUÉS West-GlobeNewswire

NSS Labs Announces 2018 Next Generation Intrusion Prevention Group Test Results

20/09/2018 - 15:00

5 Products Receive Recommended Rating; 2 Receive Caution Rating AUSTIN, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, [...]

H1 Launches ‘Strategy as a Service’ Offering That Helps Life Sciences Companies Cut Time-to-Market in Half

20/09/2018 - 15:00

DaVinci service helps clients identify and unlock valuable opportunities faster NEW YORK, Sept. 20, 2018 (GLOBE NEWSWIRE) -- H1 , the first company to arm healthcare organizations with live data insights to help fight [...]

Auxly Announces Strategic Investment in FSD Pharma

20/09/2018 - 14:45

VANCOUVER, British Columbia, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") is pleased to announce that, as part of the strategic alliance and [...]

Teladoc Health Launches Teladoc Global Care Services

20/09/2018 - 14:35

Unique new offering enables multinational employers and insurers to seamlessly provide access to care for individuals while abroad PURCHASE, NY, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global [...]

North Bud Farms Closes $944,500 Private Placement

20/09/2018 - 14:30

TORONTO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- North Bud Farms Inc . (CSE: NBUD) (the " Corporation "), is pleased to announce the closing of a non-brokered private placement offering (the " Private Placement ") consisting [...]

Portola Pharmaceuticals Names Scott Garland President and Chief Executive Officer

20/09/2018 - 14:30

– Relypsa president and former Exelixis chief commercial officer brings significant commercial and operational expertise – – Commercial responsibility for two of the industry’s most successful therapies, Avastin and [...]

Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials

20/09/2018 - 14:30

RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today [...]

Novo Nordisk - Oral semaglutide demonstrates greater reductions in HbA1c and body weight and comparable number of adverse events vs dulaglutide in Japanese people with type 2 diabetes

20/09/2018 - 14:17

Bagsværd, Denmark, 20 September 2018 - Novo Nordisk today announced the headline results from PIONEER 10, a phase 3a trial with oral semaglutide vs once-weekly subcutaneous dulaglutide, both in combination with one oral [...]

Acarix CADScor®System for early rule-out of Coronary Artery Disease (CAD) gains traction from established German users.

20/09/2018 - 14:13

Press release Malmö, September 20, 2018 Acarix CADScor ® System for early rule-out of Coronary Artery Disease (CAD) gains traction from established German users. Acarix AB (publ) ("Acarix"), today reported positive [...]

Avid Bioservices to Exhibit at the 17th Annual Contracting & Outsourcing Conference

20/09/2018 - 14:05

-- Participation at One-Day Tabletop Exhibition to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- [...]

Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

20/09/2018 - 14:03

Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease on September 25-27 in New York City Cantor Fitzgerald Global Healthcare Conference on October 1-3 in New York City CORAL GABLES, Fla., Sept. 20, 2018 [...]

Selecta Biosciences to Present at the Jefferies Gene Therapy Summit on September 27, 2018

20/09/2018 - 14:00

WATERTOWN, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

Iterum Therapeutics to Present Clinical Data on Antibiotic Sulopenem at IDWeek 2018

20/09/2018 - 14:00

DUBLIN, Ireland and CHICAGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today [...]

Wave Life Sciences to Present New Data on Its DMD Exon 53 Skipping Program and Discovery Platform at Upcoming Meetings

20/09/2018 - 14:00

CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined [...]

OncoMed Provides Update on Navicixizumab Partnership

20/09/2018 - 14:00

REDWOOD CITY, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ: OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]

Tetra Bio-Pharma Announces Significant Progress on Storz & Bickel Co-Development in Treating Fibromyalgia

20/09/2018 - 14:00

ORLEANS, Ontario, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), has made significant progress in its co- [...]

XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team

20/09/2018 - 14:00

AUSTIN, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the addition of Alice Gottlieb, M.D., Ph.D., to its Scientific Advisory Board (SAB). Dr. Alice Gottlieb is internationally [...]

Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial

20/09/2018 - 14:00

Combination immunotherapy of GR-MD-02 and KEYTRUDA for all cohorts reported shows an Objective Response Rate of 50% (seven of fourteen patients). The published response rate of KEYTRUDA alone is 33% in melanoma [...]

Maverick Technology Solutions Receives Approval for Name Change and Symbol Change

20/09/2018 - 14:00

Concludes Final Step of Its Merger RENO, Nev., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions, developer and manufacturer of the ROSINBOMB brand of industry leading consumer and commercial rosin [...]